Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 2, 2010, Pages 145-152

  Goffus, Andrea M ^a   Anderson, Gail D ^b   Hoane, Michael R ^a  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Behavior; Brain injury; Neurorehabilitation; Restorative neurology; Therapy

Indexed keywords

BRAIN INJURY; CLINICAL POPULATION; DETRIMENTAL EFFECTS; FUNCTIONAL RECOVERY; NEUROREHABILITATION; NICOTINAMIDE ADENINE DINUCLEOTIDES; RECOVERY OF FUNCTIONS; STATISTICAL ANALYSIS; TRAUMATIC BRAIN INJURIES;

AMIDES; BODY FLUIDS; BRAIN; NEUROLOGY; NEUROMUSCULAR REHABILITATION; PUMPS; RECOVERY;

ANIMALS;

NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; LOCOMOTION; MALE; NONHUMAN; OSMOTIC MINIPUMP; RAT; SENSORIMOTOR FUNCTION; TOUCH; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DRUG ADMINISTRATION SCHEDULE; MALE; NIACINAMIDE; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN B COMPLEX;

ANIMALIA; RATTUS;

EID: 77953706144     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.2.11315     Document Type: Article

References (36)

1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006; 21:10-7.
2. Thurman DJ, Alverson CA, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 1999; 14:602-15. (Pubitemid 30027268)
3. Gondusky JS, Reiter MP. Protecting military convoys in Iraq: an examination of battle injuries sustained by a mechanized battalion during Operation Iraqi Freedom II. Mil Med 2005; 170:546-9.
4. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, et al. Clinical trials in head injury. J Neurotrauma 2002; 19:503-57.
5. Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. Curr Opin Pharm 2003; 3:27-32.
6. Statler KD, Jenkins LW, Dixon CE, Clark RS, Marion DW, Kochanek PM. The simple model versus the super model: translating experimental traumatic brain injury research to the bedside. J Neurotrauma 2001; 18:1195-206.
7. Sullivan PG, Keller JN, Mattson MP, Scheff SW. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J Neurotrauma 1998; 15:789-98.
8. Verbois SL, Scheff SW, Pauly JR. Chronic nicotine treatment attenuates alpha7 nicotinic receptor deficits following traumatic brain injury. Neuropharmacology 2003; 44:224-33.
9. Cutler SM, Pettus EH, Hoffman SW, Stein DG. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 2005; 195:423-9.
10. 3 improves functional recovery and reduces GFAP expression following traumatic brain injury in the rat. J Neurotrauma 2003; 20:1189-98.
11. Hoane MR, Gilbert DR, Holland MA, Pierce JL. Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain. Neurosci Lett 2006; 35-9.
12. Hoane MR, Kaplan SA, Ellis AL. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res 2006; 1125:185-93.
13. Hoane MR, Pierce JL, Holland MA, Anderson GD. Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat. Neuroscience 2008; 154:861-8.
14. Hoane MR, Pierce JL, Kaufman NA, Beare JE. Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage. Oxid Med Cell Longev 2008; 1:46-53.
15. Hoane MR, Tan AA, Pierce JL, Anderson GD, Smith DC. Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J Neurotrauma 2006; 23:1535-48.
16. Holland MA, Tan AA, Smith DC, Hoane MR. Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. J Neurotrauma 2008; 25:140-52.
17. Quigley A, Tan AA, Hoane MR. The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat. Brain Res 2009; 1304:138-48.
18. + depletion and improves water maze performance after traumatic brain injury in mice. J Neurotrauma 2007; 24:1399-405.
19. Chong ZZ, Maiese K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr Neurovasc Res 2008; 5:159-70.
20. Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules 2009; 14:3446-85.
21. 3: from metabolism to therapies. J Pharmacol Exp Ther 2008; 324:883-93.
22. +, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 2003; 69:150-7.
23. Yang J, Klaidman LK, Adams JD. Medicinal chemistry of nicotinamide in the treatment of ischemia and reperfusion. Mini Rev Med Chem 2002; 2:125-34.
24. Ayoub IA, Lee EJ, Ogilvy C, Flint Beal M, Maynard KI. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in wistar rats. Neurosci Lett 1999; 259:21-4. (Pubitemid 29051532)
25. Ayoub IA, Maynard KI. Therapeutic window for nicotinamide following transient focal cerebral ischemia. Neuroreport 2002; 11:213-6.
26. Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P, et al. Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav 2002; 73:901-10. (Pubitemid 35246240)
27. Maiese K, Chong ZZ. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci 2003; 24:228-32. (Pubitemid 36588870)
28. Spector R. Niacin and nicotinamide transport in the central nervous system. J Neurochem 1979; 33:895-904. (Pubitemid 10237581)
29. Maynard KI, Ayoub IA, Shen C. Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to two weeks following transient focal cerebral ischemia in wistar rats. Ann N Y Acad Sci 2001; 939:416-24.
30. + precursor nicotinamide. Curr Med Chem 2006; 13:883-95.
31. Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003; 131:48-52. (Pubitemid 36098821)
32. Hoane MR, Pierce JL, Holland MA, Birky ND, Dang T, Vitek MP, et al. The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury. J Neurotrauma 2007; 24:1108-18. (Pubitemid 47106285)
33. Schallert T, Woodlee MT. Orienting and Placing. In: Whishaw IQ, Kolb B, eds. The Behavior of the Laboratory Rat. New York: Oxford University Press 2005; 129-40.
34. Kalhorn TF, Thummel KE, Nelson SD, Slattery JT. Analysis of oxidized and reduced pyridine dinucleotides in rat liver by high-performance liquid chromatography. Ann Biochem 1985; 151:343-7.
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Elsevier 2005.
36. Coggeshall RE. A consideration of neural counting methods. TINS 1992; 15:9-13.